| Market Cap | 513M 447M 412M 388M 725M 48.37B 730M 4.9B 1.9B 23.84B 1.93B 1.89B 82.62B | P/E 2017 |
-17.4x | P/E 2018 | -41.8x |
|---|---|---|---|---|---|
| Enterprise Value | 460M 401M 370M 348M 650M 43.37B 655M 4.4B 1.71B 21.37B 1.73B 1.69B 74.07B | EV / Sales 2017 |
53,919,197x | EV / Sales 2018 | 19,487,976x |
| Free-Float |
80.58% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -8.86% | - | - | 352M | |
| -0.98% | -3.41% | -12.82% | -9.24% | 12.91B | |
| -1.84% | -4.35% | -35.06% | -57.81% | 4.86B | |
| -3.47% | -8.90% | -12.91% | -6.91% | 4.5B | |
| +0.29% | -0.99% | +14.53% | -16.19% | 3.8B | |
| +0.47% | -2.97% | +4.82% | -43.79% | 3.7B | |
| -1.30% | -4.39% | -6.53% | -11.27% | 3.58B | |
| -0.07% | -1.67% | -10.08% | -3.49% | 3.12B | |
| -0.71% | +3.95% | -6.26% | -26.47% | 2.4B | |
| -1.61% | -8.55% | -14.35% | +29.97% | 1.7B | |
| Average | -0.92% | -3.87% | -8.74% | -16.13% | 4.51B | |
| Weighted average by Cap. | -1.07% | -4.31% | -10.24% | -17.71% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 3.08 2.68 2.47 2.33 4.35 290.09 4.38 29.41 11.42 142.96 11.55 11.31 495.49 | 18.69 16.29 15.01 14.12 26.42 1.76K 26.61 178.63 69.37 868.2 70.16 68.66 3.01K |
| Net income | -8.89M -7.75M -7.14M -6.72M -12.57M -838M -12.66M -84.97M -33M -413M -33.37M -32.66M -1.43B | -8.41M -7.33M -6.76M -6.36M -11.89M -793M -11.98M -80.4M -31.22M -391M -31.58M -30.91M -1.35B |
| Net Debt | -1.84M -1.6M -1.48M -1.39M -2.6M -173M -2.62M -17.57M -6.82M -85.41M -6.9M -6.75M -296M | -53.08M -46.25M -42.63M -40.1M -75.02M -5B -75.54M -507M -197M -2.47B -199M -195M -8.54B |
Employees
-
Sector
Pharmaceuticals
